看多

Short term pt 20 but <25

160
Play is based on positive news or not in Mid 2020, if positive PH3, we will see explosive move again to as high as 40 - 60 but if negative, we can see ~15s --- It is good longer term stock since they do have a drug approved already and have plenty of cash on hand to hget the drug to the market - 240 sales reps and had $224 million in cash and equ. In my opinion, its a decent - good long term stock to hold.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。